FMC Corporation is a global agricultural sciences company dedicated to providing farmers with innovative solutions that increase the productivity and resilience of their land. We operate in a single distinct business segment. We develop, market and sell all three major classes of crop protection chemicals (insecticides, herbicides and fungicides) as well as biologicals, crop nutrition, and seed treatment products, which we group as plant health. FMC's innovative crop protection solutions help growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC is committed to discovering new insecticide, herbicide, and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. We are a tier-one leader in the agrochemicals/crop protection market. Our position in the market is driven by our technology and innovation, as well as our geographic balance and crop diversity. As announced in February 2026, the FMC Board of Directors has authorized the exploration of strategic options, including but not limited to, the sale of the company to unlock shareholder value and ensure that the growth and core portfolios are best positioned for long-term success. FMC's four new active ingredients, along with its broader development pipeline, are unique and transformative.
Logo and founding year from Wikidata.
As recorded by the SEC for this filer.
As recorded by the SEC for this filer.
No related securities.
No related securities.
| Dec FY2014 | 3.3B |
|---|---|
| Dec FY2015 | 2.5B |
| Dec FY2016 | 2.3B |
| Dec FY2017 | 2.5B |
| Dec FY2018 | 4.3B |
| Dec FY2019 | 4.6B |
| Dec FY2020 | 4.6B |
| Dec FY2021 | 5B |
| Dec FY2022 | 5.8B |
| Dec FY2023 | 4.5B |
| Dec FY2024 | 4.2B |
| Dec FY2025 | 3.5B |
| Sep Q3 FY23 | 981.9M |
|---|---|
| Dec Q4 FY23 | 1.1B |
| Mar Q1 FY24 | 918M |
| Jun Q2 FY24 | 1B |
| Sep Q3 FY24 | 1.1B |
| Dec Q4 FY24 | 1.2B |
| Mar Q1 FY25 | 791.4M |
| Jun Q2 FY25 | 1.1B |
| Sep Q3 FY25 | 542.2M |
| Dec Q4 FY25 | 1.1B |
| Mar Q1 FY26 | 758.6M |
| Jun Q2 FY26 | 867.1M |